Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11291830rdf:typepubmed:Citationlld:pubmed
pubmed-article:11291830lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:11291830lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:11291830lifeskim:mentionsumls-concept:C0023413lld:lifeskim
pubmed-article:11291830lifeskim:mentionsumls-concept:C0042874lld:lifeskim
pubmed-article:11291830lifeskim:mentionsumls-concept:C0920321lld:lifeskim
pubmed-article:11291830lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:11291830pubmed:issue1lld:pubmed
pubmed-article:11291830pubmed:dateCreated2001-4-6lld:pubmed
pubmed-article:11291830pubmed:abstractTextSix patients with incurable malignancies were originally treated with vitamin E, 3200 IU/day for fourteen days, followed by the same dose of vitamin E daily plus LCV (20 mg/m2 i.v. bolus daily x 5) with 5FU (425 mg/m2 i.v. bolus immediately following LCV). The same schedule of LCV and 5FU was repeated 4 weeks later, then every 5 weeks indefinitely. When 3 of the first 6 had grade 3/4 toxicity, six more patients were treated on the identical drugs and schedule. Seven of twelve total patients had one or more grade 3/4 toxicities. Neutropenia, abdominal pain, and diarrhea were most common. No patient had a documented response, though seven patients did have stable disease. Though the combination of vitamin E and chemotherapy was toxic, this trial demonstrated maximal therapeutic doses of vitamin E can be combined with standard 5FU and LCV, without significantly increasing the side effects of the chemotherapy itself.lld:pubmed
pubmed-article:11291830pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11291830pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11291830pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11291830pubmed:languageenglld:pubmed
pubmed-article:11291830pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11291830pubmed:citationSubsetIMlld:pubmed
pubmed-article:11291830pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11291830pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11291830pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11291830pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11291830pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11291830pubmed:statusMEDLINElld:pubmed
pubmed-article:11291830pubmed:issn0167-6997lld:pubmed
pubmed-article:11291830pubmed:authorpubmed-author:MorrowJJlld:pubmed
pubmed-article:11291830pubmed:authorpubmed-author:RothenbergMMlld:pubmed
pubmed-article:11291830pubmed:authorpubmed-author:JohnsonD HDHlld:pubmed
pubmed-article:11291830pubmed:authorpubmed-author:BeauchampR...lld:pubmed
pubmed-article:11291830pubmed:authorpubmed-author:CoffeyRRlld:pubmed
pubmed-article:11291830pubmed:authorpubmed-author:MILLSMMlld:pubmed
pubmed-article:11291830pubmed:authorpubmed-author:ShyrYYlld:pubmed
pubmed-article:11291830pubmed:authorpubmed-author:ChineryRRlld:pubmed
pubmed-article:11291830pubmed:authorpubmed-author:BlankeC DCDlld:pubmed
pubmed-article:11291830pubmed:authorpubmed-author:StipanovMMlld:pubmed
pubmed-article:11291830pubmed:issnTypePrintlld:pubmed
pubmed-article:11291830pubmed:volume19lld:pubmed
pubmed-article:11291830pubmed:ownerNLMlld:pubmed
pubmed-article:11291830pubmed:authorsCompleteYlld:pubmed
pubmed-article:11291830pubmed:pagination21-7lld:pubmed
pubmed-article:11291830pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:11291830pubmed:meshHeadingpubmed-meshheading:11291830...lld:pubmed
pubmed-article:11291830pubmed:meshHeadingpubmed-meshheading:11291830...lld:pubmed
pubmed-article:11291830pubmed:meshHeadingpubmed-meshheading:11291830...lld:pubmed
pubmed-article:11291830pubmed:meshHeadingpubmed-meshheading:11291830...lld:pubmed
pubmed-article:11291830pubmed:meshHeadingpubmed-meshheading:11291830...lld:pubmed
pubmed-article:11291830pubmed:meshHeadingpubmed-meshheading:11291830...lld:pubmed
pubmed-article:11291830pubmed:meshHeadingpubmed-meshheading:11291830...lld:pubmed
pubmed-article:11291830pubmed:meshHeadingpubmed-meshheading:11291830...lld:pubmed
pubmed-article:11291830pubmed:meshHeadingpubmed-meshheading:11291830...lld:pubmed
pubmed-article:11291830pubmed:meshHeadingpubmed-meshheading:11291830...lld:pubmed
pubmed-article:11291830pubmed:meshHeadingpubmed-meshheading:11291830...lld:pubmed
pubmed-article:11291830pubmed:meshHeadingpubmed-meshheading:11291830...lld:pubmed
pubmed-article:11291830pubmed:meshHeadingpubmed-meshheading:11291830...lld:pubmed
pubmed-article:11291830pubmed:meshHeadingpubmed-meshheading:11291830...lld:pubmed
pubmed-article:11291830pubmed:meshHeadingpubmed-meshheading:11291830...lld:pubmed
pubmed-article:11291830pubmed:meshHeadingpubmed-meshheading:11291830...lld:pubmed
pubmed-article:11291830pubmed:meshHeadingpubmed-meshheading:11291830...lld:pubmed
pubmed-article:11291830pubmed:meshHeadingpubmed-meshheading:11291830...lld:pubmed
pubmed-article:11291830pubmed:year2001lld:pubmed
pubmed-article:11291830pubmed:articleTitleA phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignancies.lld:pubmed
pubmed-article:11291830pubmed:affiliationDepartment of Medicine, Oregon Health Sciences University, Portland 97232, USA.lld:pubmed
pubmed-article:11291830pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11291830pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:11291830pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11291830pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:11291830pubmed:publicationTypeClinical Trial, Phase Illd:pubmed